Remove Lipid disorders Remove Outcomes Remove Research
article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable risk factors. Key Takeaways: Up to 50% of all dementia cases could potentially be prevented or substantially delayed.

article thumbnail

Harnessing Telehealth and Home Blood Pressure Monitoring to Improve Hypertension Care

Cardiometabolic Health Congress

Whether it’s providing tech support, advocating for EHR integration, or offering video visits, we can leverage these advancements to improve patient outcomes. Subscribe below for the latest cardiorenal metabolic news, research, and innovations to advance your career and practice!

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4 1,2 The primary composite outcome occurred in 6.5% 1,2 The primary composite outcome occurred in 6.5% Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

Obesity 111